Palo Verde Hematology & Onclgy is categorized under Hematologists in Phoenix, AZ .
Palo Verde Hematology & Onclgy was established in 0, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Hematologists business, which does work in the B2C market, and is classified as a Hematologists, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Gloria Piazza at the company’s single location by writing to 9250 West Thomas Road # 150, Phoenix, Arizona AZ 85037 or by phoning (623) 478-8091. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Palo Verde Hematology & Onclgy |
| Contact Person: | Gloria Piazza |
| Address: | 9250 West Thomas Road # 150, Phoenix, Arizona 85037 |
| Phone Number: | (623) 478-8091 |
| Website Address: | pvhomed.com |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Hematologists |
| SIC Code: | 8011 |
| NAICS Code: | 6214930 |
| Share This Business: |
Palo Verde Hematology & Onclgy was started in 0 to provide professional Hematologists under the SIC code 8011 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Gloria Piazza for inquiries that concern Palo Verde Hematology & Onclgy by calling the company number (623) 478-8091, as your correspondence is most welcome. Additionally, the physical location of the single location of Palo Verde Hematology & Onclgy can be found at the coordinates 33.47968,-112.26092 as well as the street address 9250 West Thomas Road # 150 in Phoenix, Arizona 85037.
For its online presence, you may visit Palo Verde Hematology & Onclgy’s website at pvhomed.com and engage with its social media outlets through on Twitter and on Facebook.